Background: Despite the high incidence of in-hospital cardiac arrest (IHCA) in US hospitals, the prognosis and end-of-life decision-making patterns of a patient with a recurrent IHCA are unknown. Methods: Within Get-With-The-Guidelines-Resuscitation, we identified 192,250 patients from 711 hospitals with an IHCA from 2000 to 2015. Patients were categorized as having no recurrent IHCA (only 1 event), recurrent IHCA (≥2 IHCAs), and recurrent out-of-hospital cardiac arrest (OHCA), defined as an IHCA after an OHCA. Using multivariable hierarchical logistic regression, rates of survival to discharge and favorable neurological survival (mild or no disability) between the 3 groups were compared. Rates of de novo "do not attempt resuscitation" (DNAR) and withdrawal of care orders among successfully resuscitated patients were also evaluated. . Despite worse survival outcomes, patients with recurrent IHCA were least likely to adopt DNAR orders within the first 24 hours after successful resuscitation compared with patients with no recurrent IHCA or recurrent OHCA (17.2% vs 18.9% and 26.6%, respectively) or withdraw care at any time (17.7% vs 24.4% and 31.2%, respectively). Conclusions: Nearly 1 in 8 patients with an IHCA has a recurrent IHCA, and these patients have worse outcomes than patients with only a single IHCA and those with an IHCA after being hospitalized for an OHCA. Despite worse survival, rates of DNAR and withdrawal of care were lowest for patients with recurrent IHCA. These findings provide important prognostic information for clinicians caring for patients with recurrent IHCA and suggest the need to better align resuscitation and end-of-life decisions with patients' prognoses after IHCA.
with a recurrent IHCA during the same hospitalization and the associated prognosis of a recurrent IHCA remain unknown. Whether there are differences in outcomes between patients with a recurrent arrest in which the index arrest was an IHCA versus an out-of-hospital cardiac arrest (OHCA) also has not been examined. A better understanding of the epidemiology and prognosis of recurrent IHCA could provide useful information for clinicians and families. Additionally, if patients with recurrent IHCA have worse survival outcomes, patterns of decision making regarding "do not attempt resuscitation" (DNAR) orders and withdrawal of care between those with and without a recurrent IHCA are important to understand, as end-of-life decisions in patients with IHCA have not always been aligned with patients' prognoses. 3 Accordingly, within a large national registry, we examined the frequency with which a patient with an IHCA has a recurrent IHCA during a hospitalization and whether rates of survival to discharge and favorable neurological survival for patients with a recurrent IHCA differ from those with only a single IHCA event or those with an IHCA after an initial OHCA. Moreover, we evaluated patterns of end-of-life care among those with return of spontaneous circulation (ROSC) among these 3 patient groups, with a focus on de novo DNAR and withdrawal of care orders after successful resuscitation.
Methods

Data sources
GWTG-Resuscitation is a large, prospective, national qualityimprovement registry of IHCA and is sponsored by the American Heart Association. Its design has been previously described in detail. 4 In brief, trained hospital personnel identify all patients without donot-resuscitate orders with a cardiac arrest (defined as absence of a palpable central pulse, apnea, and unresponsiveness) and who undergo cardiopulmonary resuscitation. Cases are identified by multiple methods, including centralized collection of cardiac arrest flow sheets; reviews of hospital paging system logs; and routine checks of code carts, pharmacy tracer drug records, and hospital billing charges for resuscitation medications. 4 The registry uses standardized Utstein-style definitions for all patient variables and outcomes to facilitate uniform reporting across hospitals. 5, 6 In addition, data accuracy is ensured by rigorous certification of hospital staff and use of standardized software with data checks for completeness and accuracy.
Study population
The study cohort included 192,250 patients with at least 1 IHCA from 711 acute-care hospitals that submitted data to GWTG-Resuscitation between January 1, 2000, and December 31, 2015. As we were interested in comparing patients with no recurrent IHCA with those who had a recurrent cardiac arrest, we categorized patients into 3 groups: (1) no recurrent IHCA (only 1 IHCA event); (2) recurrent IHCA, defined as ≥2 cardiac arrests during the same hospitalization in which the initial cardiac arrest was an IHCA; and (3) recurrent OHCA, defined as an IHCA occurring in a patient with an initial OHCA.
Study outcomes
The primary outcome was survival to hospital discharge, and the secondary outcome was favorable neurological survival. Based on prior work showing large prognostic differences in long-term survival between patients with a discharge cerebral performance category (CPC) score of 1 versus 2, favorable neurological survival was defined as survival to hospital discharge with a discharge CPC score of 1.
7 A CPC score of 1 denotes patients with mild to no neurological disability, 2 for moderate neurological disability, 3 for severe neurological disability, and 4 for coma or vegetative state. For descriptive purposes, we also examined the proportion of patients in each of the 3 groups with ROSC who were made DNAR. Rates of DNAR were examined after successful resuscitation from the second cardiac arrest for patients with recurrent IHCA or recurrent OHCA and after the index cardiac arrest for patients with no recurrent IHCA because this latter group of patients would not have had a second cardiac arrest. Because many patients who eventually die have DNAR orders closer to the time of death, and as we were interested in examining whether DNAR decisions correlated with an index or recurrent cardiac arrest, we defined DNAR status as a patient for whom a DNAR order was placed within 24 hours after ROSC, based on our prior work, 3 but also examined rates of DNAR at any time after ROSC in the 3 patient groups. Furthermore, we compared rates of withdrawal of care (i.e., "comfort care") among patients with no recurrent IHCA, recurrent IHCA, and recurrent OHCA who achieved ROSC.
Statistical analysis
Baseline differences between patients with no recurrent IHCA, recurrent IHCA, and recurrent OHCA were evaluated using χ 2 tests for categorical variables and analysis of variance for continuous variables. To evaluate differences in survival outcomes between patients with no recurrent IHCA versus those with recurrent IHCA, we constructed multivariable hierarchical logistic regression models. Hierarchical logistic regression was used to account for clustering of patients within hospitals, 8 Separate models were constructed to examine differences in rates of survival to discharge and favorable neurological survival between patients with no recurrent IHCA and those with a recurrent IHCA. Similarly, separate multivariable hierarchical logistic regression models were constructed to evaluate differences in these 2 outcomes between patients with recurrent OHCA and those with recurrent IHCA.
Data on discharge neurological status were missing in 7,584 (3.9%) patients and were assumed to be missing at random. IVEWARE software was used to perform multiple imputations with 10 data sets, the results of which were pooled. 10 Results with and without imputation were not meaningfully different, so only the former are presented. All other study analyses were performed with SAS 9.2 (SAS Institute, Cary, NC) and R version 2.10.0. 11 The institutional review board of the Mid America Heart Institute waived the requirement of informed consent, and the American Heart Association's GWTG-Resuscitation research and publications committee approved the final manuscript draft.
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Results
Of 192,250 patients with IHCA, 165,446 (86.1%) had no recurrent IHCA, 23,643 (12.3%) had recurrent IHCA, and 3161 (1.6%) had recurrent OHCA. Compared with patients with no recurrent IHCA, patients with recurrent IHCA were younger; were more frequently female and of black race; and had higher rates of respiratory insufficiency, renal insufficiency, hepatic insufficiency, hypotension, sepsis, and metabolic and electrolyte abnormalities prior to their index cardiac arrest (Table I) . Also, compared with those with no recurrent IHCA, patients Characteristics for the recurrent IHCA and OHCA groups are based on the second cardiac arrest event for these patients. IQR, interquartile range; NA, not applicable; CNS, central nervous system. ⁎ Index event code duration is not available for patients with recurrent OHCA (as the event occurred outside the hospital), and recurrent event code duration is not available for patients with no recurrent arrest events.
† Initial cardiac arrest rhythm was for the index IHCA event for each group. Asystole  3486  2714  366  296  6862  PEA  2454  8365  531  495  11,845  VF  457  733  1222  404  2816  VT  347  612  343  818  2120  Total  6744  12,424  2462  2013  23,643 Patients with a recurrent IHCA were likely to have the same cardiac arrest rhythm as with their initial IHCA, but there was no consistent pattern. PEA, pulseless electrical activity; VF, ventricular fibrillation; PVT, pulseless ventricular tachycardia. Table III) . DNAR rates at any time after ROSC were also lower for patients with recurrent IHCA than for patients with no recurrent IHCA (35.4% vs 43.9%) (Table IV) . Similarly, rates for withdrawal of care at any time after ROSC were lower for patients with recurrent IHCA than for patients with no recurrent IHCA (17.7% vs 24.4%, P b .001).
Prognosis of recurrent IHCA versus recurrent OHCA
Of 3,161 patients with recurrent OHCA, 508 (16.1%) survived to hospital discharge, as compared to 2,995 (12.7%) patients with recurrent IHCA. The mean time from the index arrest to the recurrent arrest was similar between patients with a recurrent IHCA (2.2 ± SD of 9.3 days) and a recurrent OHCA (2.5 ± 14.2 days; P = .25), as was the median duration of the recurrent resuscitation event in the 2 groups (Table I) . After adjusting for differences in demographics and patient characteristics, patients with recurrent IHCA had a 19% lower odds of surviving to hospital discharge as compared with those with recurrent OHCA (adjusted OR: 0.81; 95% CI: 0.71-0.94; P = .005) (Table III) . Additionally, patients with recurrent IHCA were less likely to have favorable neurological survival than those with recurrent OHCA (7.0% vs 8.9%; adjusted OR: 0.66; 95% CI: 0.54-0.81; P b .001).
However, among patients who achieved ROSC, compared with patients with recurrent OHCA, patients with recurrent IHCA were less likely to be made DNAR within the first 24 hours (17.2% vs 26.6%; P b .001) or at any time after ROSC (35.4% vs 48.9%) (Table IV) . Moreover, withdrawal of care rates at any time after ROSC were lower for patients with recurrent IHCA than for patients with recurrent OHCA (17.7% vs 31.2%, P b .001).
Discussion
In a contemporary national registry of IHCA, we found that 1 in 8 patients with an IHCA had a recurrent IHCA. Patients with recurrent IHCA were less than half as likely to survive to hospital discharge or have favorable neurological survival than patients with only one IHCA. Compared to patients with an OHCA who subsequently had an IHCA, patients with a recurrent IHCA were 19% less likely to survive to discharge and 34% less likely to have favorable neurological survival. Despite worse outcomes, patients with recurrent IHCA were the least likely to be made DNAR or to have withdrawal of care after being successfully resuscitated for a second time. Collectively, our findings provide important insights into the incidence and prognosis of patients with recurrent IHCA and suggest that current patterns of care regarding DNAR and withdrawal of care decisions among patients with a recurrent cardiac arrest are not well aligned with their prognoses.
To our knowledge, this is the first study to describe the outcomes of adult patients with recurrent IHCA. This is because, until recently, large registries of patients with IHCA have not been available. Worse outcomes among patients with a recurrent IHCA are not altogether surprising, especially given that we found that patients with a recurrent IHCA were sicker than those with no recurrent IHCA, although they were also younger. Our adjusted models accounted for these differences, and we were able to quantify the extent to which patients with a recurrent IHCA were likely to survive to discharge or have favorable neurological survival compared with patients with no recurrent IHCA. Such information can be used by clinicians to better inform families and patients with a recurrent IHCA about their prognosis. In addition, our findings provide preliminary insights into the prognosis of patients with an index OHCA who were successfully resuscitated and who subsequently had an IHCA, wherein nearly 1 in 5 patients survived to discharge.
Contrary to our expectations, patients with recurrent IHCA who achieved ROSC had lower rates of DNAR and withdrawal of care orders than patients either with no recurrent IHCA or with recurrent OHCA despite the fact that patients with recurrent IHCA had lower survival rates. This was the case for DNAR orders within the first 24 hours or at any time after ROSC. We did find that patients with recurrent IHCA were nearly 3 years younger than those with no recurrent IHCA, which may have explained some of the differences in DNAR rates, but we also found that patients with recurrent IHCA were sicker and had higher illness severity. These patterns were surprising because DNAR orders and withdrawal of care decisions are typically adopted by patients who have the worst perceived prognosis. Indeed, our findings suggest a corollary End-of-life care orders among patients who achieve ROSC after a cardiac arrest are summarized for each of the 3 groups. ⁎ P value reflects comparisons between patients with recurrent IHCA and those with no recurrent IHCA. † P value reflects comparisons between patients with recurrent IHCA and those with recurrent OHCA.
to the risk-treatment paradox in medicine-a risk to end-of-life decision-making paradox, whereby those with the worst prognosis are the least likely to be made DNAR or to have care withdrawn. Indeed, a prior study found that DNAR orders among patients with IHCA who achieved ROSC were not always aligned with patients' prognoses. 3 Our study extends those initial findings and suggests that efforts to better communicate prognoses after IHCA with patients and their families may be needed. Our study should be interpreted in the context of the following potential limitations. First, this study analyzed data from patients in a large national quality improvement registry, and survival outcomes of patients in nonparticipating hospitals may differ, although there is no a priori reason to expect that our study findings by patients' recurrent IHCA status would differ at other centers. Second, although our models were able to adjust for a wide range of patient variables, the possibility for unmeasured confounding still exists. Third, for the cohort of patients with recurrent OHCA, we only examined patients with an IHCA after being hospitalized for an index OHCA, and patients with multiple OHCAs but without a subsequent IHCA were not included in the study because GWTG-Resuscitation collects data only on patients with IHCA. Therefore, our analyses for patients with recurrent OHCA should be interpreted in this context. Fourth, patient preferences on DNAR and withdrawal of care decisions were not collected within the registry, so we were unable to determine if the risk to end-of-life decision-making paradox we observed was due to patient preferences or physician recommendations.
Conclusions
Recurrent IHCA occurs in nearly 1 in 8 patients with an initial IHCA and is associated with lower rates of survival to discharge and favorable neurological survival than patients with only a single IHCA and those with an IHCA after being hospitalized for an OHCA. Despite worse survival outcomes, rates of DNAR and withdrawal of care were lowest for patients with recurrent IHCA. These findings provide important prognostic information for clinicians and families of patients with recurrent IHCA and suggest a critical need to better align resuscitation and end-oflife decision-making with patients' prognoses after IHCA.
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